Association of Peripheral Blood Mononuclear Cell to HDL Cholesterol Ratio with Papillary Thyroid Carcinoma in Different Genders
1.Laboratory Department of North China University of Science and Technology Affiliated Hospital, Tangshan 063200, China 2.Department of Functional Examination, the Second Hospital of Tangshan, Tangshan 063200, China 3.North China University of Science and technology, Tangshan 063200, China
LI Zhiyong,LI Guohua,HUANG Pengfei, et al. Association of Peripheral Blood Mononuclear Cell to HDL Cholesterol Ratio with Papillary Thyroid Carcinoma in Different Genders[J]. Chinese General Practice, 2024, 27(25): 3159-3163. DOI: 10.12114/j.issn.1007-9572.2023.0524.
李志勇,李国华,黄鹏飞等. 不同性别人群外周血单核细胞与高密度脂蛋白胆固醇比与甲状腺乳头状癌的关联性研究[J]. 中国全科医学, 2024, 27(25): 3159-3163. DOI: 10.12114/j.issn.1007-9572.2023.0524.
LIZ Y,LINW X,ZHENGJ H,et al. Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer[J]. Bioscience Reports,2021,41(2):undefined. DOI:10.1042/BSR20204086.
[2]
MEGWALUU C,MOONP K. Thyroid cancer incidence and mortality trends in the United States:2000-2018[J]. Thyroid:Official Journal of the American Thyroid Association,2022,32(5):560-570. DOI:10.1089/thy.2021.0662.
WANGT S,EVANSD B. Commentary on:occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection:a multi-institutional study[J]. Surgery,2017,161(2):472-474.
[6]
KODAK,KATOHM,YASUHARAK. Management of anaplastic thyroid cancer and proposed treatment guidelines—a 5-year case series study[J]. Cancer Reports(Hoboken),2022,5(11):e1727. DOI:10.1002/cnr2.1727.
BENCHAMAO,MALAMASM S,PRAVEENK,et al. Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase(NAAA)[J]. Scientific Reports,2022,12(1):22255.
YOKOTAM,KATOHH,NISHIMIYAH,et al. Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer[J]. The Journal of Surgical Research,2020,246:535-543. DOI:10.1016/j.jss.2019.09.034.
[14]
HUIN,BARTERP J,ONGK L,et al. Altered HDL metabolism in metabolic disORders:insights into the therapeutic potential of HDL[J]. Clinical Science(London),2019,133(21):2221-2235. DOI:10.1042/CS20190873.
XUH Z,PANGY F,LIX Q,et al. Monocyte to high-density lipoprotein cholesterol ratio as an independent risk factor for papillary thyroid carcinoma[J]. Journal of Clinical Laboratory Analysis,2021,35(11):e24014. DOI:10.1042/CS20190873.
[18]
ALBORNOZ-CASTAÑEDAF,DÍAZ-LONDOÑOG,GARCÍA-ARENCIBIAM,et al. Estimation of blood and bone marrow doses of thyroid carcinoma patients treated with 131I through gamma spectrometry[J]. Journal of Radiological Protection:Official Journal of the Society for Radiological Protection,2018,38(4):1359-1370. DOI:10.1088/1361-6498/aae226.
[19]
LIUX Z,WANGJ M,JIY X,et al. Monocyte-to-high-density lipoprotein cholesterol ratio is associated with the presence and size of thyroid nodule irrespective of the gender[J]. Lipids in Health and Disease,2020,19(1):36.
[20]
OZMENS,TIMURO,CALIKI,et al. Neutrophil-lymphocyte ratio(NLR)and platelet-lymphocyte ratio(PLR)may be superior to C-reactive protein(CRP)for predicting the occurrence of differentiated thyroid cancer[J]. Endocrine Regulations,2017,51(3):131-136. DOI:10.1515/enr-2017-0013